Latest Production News

Brightstar Resources has received court approval to acquire Aurumin Limited, consolidating the Sandstone Gold Project and boosting its combined mineral resource to 2.4 million ounces. The acquisition positions Brightstar as a rising mid-tier gold producer in Western Australia.

Argosy Minerals has executed a spot sales contract for 16.1 metric tonnes of lithium carbonate from its Rincon project, marking a key commercial milestone amid rising lithium prices.

Tivan Limited has dispatched its inaugural acid grade fluorspar samples from the Speewah Fluorite Project to potential buyers in Japan and Asia, marking a significant step in its offtake marketing program led by Sumitomo Corporation.

Meeka Metals has reported significant shallow high-grade gold intercepts at its Andy Well underground mine, extending the Wilber lode strike by approximately 450 metres south and highlighting potential for resource growth within 200 metres depth.

Australian Agricultural Company Limited (AACo) reported a record first-half operating profit of $39.8 million, boosted by higher beef and cattle prices and volumes, alongside strategic investments in feedlot expansion and carbon projects.

Australian Agricultural Company Limited (AACo) has reported a record first-half operating profit of $39.8 million, nearly doubling from the previous year, driven by higher beef prices and strategic live cattle sales. The company’s investments in genetics, carbon projects, and global market expansion set a strong foundation for future growth.

Australian Agricultural Company Limited (AACo) has reported robust growth in its FY26 half-year results, with significant increases in operating profit, statutory EBITDA, and cattle sales driving the upbeat performance.

DevEx Resources has secured nine uranium exploration licences from Rio Tinto in the Northern Territory’s Alligator Rivers Uranium Province, significantly enlarging its exploration territory near historic high-grade deposits.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.